Ukraine Crisis: Tech Companies Cutting Ties With Russia Over Invasion

As Russia’s invasion of Ukraine continues, global technology companies have joined governments and the international business community in cutting ties with the world’s largest country over its ongoing military actions. Companies including Apple, Google, and Meta are restricting the availability of their products and services to Russian users. Similarly, AMD, Dell, TSMC, and Intel are … Read more

Two doses of Sputnik provide two times higher antibodies against Omicron than Pfizer vaccine: Study

Based on the data collected by the Spallanzani Institute and results of previous studies, heterologous boosting with Sputnik Light is the best solution to increase other vaccines’ efficacy and extend the booster protection period, they stated. A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the … Read more

Stelis Biopharma’s greenfield facility to export 50 million Sputnik Light doses

The first order the company has is an export order of 50 million doses of the Sputnik Light vaccine for Covid-19. Stelis Biopharma, the biotech division of Strides Pharma Science, on Tuesday announced that it had commissioned a large-scale fully integrated vaccine manufacturing facility at Bengaluru. It can make 720 million vaccine doses in a … Read more

India’s vaccination drive picks up for adults but long road ahead for children

Covaxin phase 2/3 studies have been completed for 2 to 17 years age group population and immunogenicity and safety data have been submitted to the Drugs Controller General of India (DCGI) for further approvals. Even as India’s cumulative Covid-19 vaccination coverage exceeds 75.89 Crore, Covid-19 vaccination of children with comorbidities in the 12 to 17 … Read more

Covid-19: Panacea Biotec starts supplying second component of Sputnik V vaccine

Sputnik V has demonstrated efficacy of 97.6% and has already received Emergency Usage Authorisation in India. The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Panacea Biotec on Tuesday announced the shipment of the second component of Sputnik V vaccine produced in India by Panacea. The second jab of the Sputnik vaccine comprises … Read more

How to spot fake Covishield, Covaxin, Sputnik V COVID-19 vaccines? Modi govt issues parameters – Check full list

Government advisory on how to identify fake vaccines The Centre shared with the states a list of parameters to identify the authenticity of the Covid vaccines being used in the country. The Health Ministry said in a letter written to the states, that it has prepared the parameters with information from the vaccine manufacturing companies … Read more

Covid-19: Sputnik, AstraZeneca-Oxford vaccine combination safe, finds RDIF study

Initial data from the interim analysis on the immunogenicity of the combined use of the AstraZeneca and Sputnik V vaccines has demonstrated a “high safety profile” and “no serious adverse events or cases of coronavirus after vaccination”, RDIF said. A study combining the first component of the Sputnik V vaccine and the AstraZeneca-Oxford University vaccine, … Read more

Dr Reddys announces commercial launch of DRDO’s anti-covid drug 2-DG; Here are its price and availability

The drug, 2-DB will be sold commercially under the brands 2DGTM. (IE Imagae) Hyderabad-based Dr Reddy’s Laboratory announced the commercial launch of the anti-Covid-19 drug, 2-Deoxy-D-Glucose (2-DG) for hospitalized moderate to severe Covid-19 patients. The anti-Covid therapeutic application of 2-DG has been jointly developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence … Read more

Revised Covid-19 vaccination policy: From state procurement to onsite registration, all you need to know

For vaccinating the middle group i.e 18 to 44 years, states can chart out their own priority depending on the vaccine supply. The revised vaccination policy has brought hopes for many who are eyeing admissions at foreign universities, job offers and also for states that have faced difficulties in procuring vaccines and managing funds. Changing … Read more